When Dr. Liz Clayborne was a resident in emergency medicine, she noticed something that would change her career trajectory. “I was struck by the number of people who came to the ER for nosebleeds. There are more than 500,000 visits to the ER annually in the U.S.,” she recalls. To her, it seemed unnecessary that so many patients ended up in the hospital for something that could – and should – be managed at home or on the field.
That insight became the spark for NasaClip, a nosebleed rescue device that combines adjustable external pressure with intranasal sponges that can be medicated. Designed to provide hands-free, mess-free relief, it’s now positioning itself as the global brand name for nosebleed emergencies.
NasaClip’s innovation is deceptively simple but profoundly effective: empower everyone, from parents to healthcare professionals, with a tool that makes life easier, safer, and more enjoyable.
From ER Doctor to Entrepreneur
Dr. Liz’s journey was anything but conventional. “It was certainly off the beaten path of a typical physician, but I competed in business plan competitions, accelerator programs, the NSF I-Corps, and eventually raised more than $4M to bring my idea to fruition,” she explains. That feat alone is remarkable – but even more so as a Black female founder breaking into the medical technology (medtech) world.
Her determination didn’t waver even during one of the toughest chapters of her life. In 2020, while six months pregnant, Dr. Liz worked on the frontlines as an ER physician in the hardest-hit hospital in Maryland during the COVID-19 pandemic. After delivering a healthy baby girl in May 2020, she used her maternity leave to join TEDCO’s Builder Fund accelerator.
That program not only gave her NasaClip’s first investment and executive management support but also set the stage for her first $1 million capital raise. By 2024, NasaClip officially launched on NasaClip.com.
What Innovation Means
For Dr. Liz, innovation is a mindset as much as it is a product. “Innovation means to bravely think outside the box and to be willing to take the risks necessary to bring your ideas into reality,” she says.
This philosophy guides NasaClip as an early-stage startup constantly striving to improve its product and expand its brand. Dr. Liz has built a “stellar team to bring unique ideas to engineering, marketing, sales, and R&D,” ensuring that innovation is embedded in every aspect of the company.
Building Beyond Nosebleeds
While the NasaClip nosebleed device is already making waves, the company’s pipeline signals an even bigger vision. “Our next innovation is developing an intranasal drug delivery device to better deploy life-saving medications such as naloxone,” Dr. Liz shares.
Naloxone is a crucial tool in reversing opioid overdoses, typically delivered as a nasal spray. But research suggests that a device like NasaClip may provide it more effectively, potentially saving even more lives. This bold expansion transforms NasaClip from a niche solution to a broader medtech platform with life-saving potential.
The Tipping Point for Growth
NasaClip’s momentum accelerated once it entered the market in 2024. Distribution opportunities are now opening across the United States and internationally. At the same time, its research into intranasal drug delivery has caught the attention of healthcare leaders and investors alike.
“NasaClip has been steadily growing since launching into the market in 2024, but has several high-growth distribution opportunities that will accelerate sales in the U.S. as well as markets abroad,” notes Dr. Liz. With both consumer adoption and clinical interest building, NasaClip is strategically positioned for what Dr. Liz and her team envision as a billion-dollar exit.
Leading by Example
NasaClip is more than a product company; it’s a story of resilience, diversity, and leadership. “NasaClip is a high-quality, diverse, and inspirational company that likes to lead by example,” says Dr. Liz.
She herself is a visible advocate for medtech and life sciences, regularly featured on podcasts, television, and at national conferences. Beyond promoting her own venture, she highlights “the importance of medtech and life science innovation and the critical need to make early-stage capital available to founders of all backgrounds.”
In this way, NasaClip contributes to Maryland’s innovation ecosystem by not only developing solutions but also inspiring other entrepreneurs to pursue bold ideas.
Looking Ahead
The company’s future is defined by both confidence and curiosity. With a firm foothold in the nosebleed market and ambitious plans for intranasal drug delivery, NasaClip represents a new breed of medtech startup: consumer-friendly, clinically relevant, and globally scalable.
“NasaClip started as a simple solution to a common problem, but its journey shows how dreams can become reality and change the world,” says Dr. Liz.
Final Word
At its core, NasaClip embodies the belief that healthcare solutions should be simple, effective, and accessible. From one ER doctor’s observation to a product now in homes and hospitals, the journey is a testament to how innovation can spring from everyday challenges.
NasaClip’s story is not just about stopping nosebleeds – it’s about starting a movement toward smarter, more inclusive medical innovation.
